| - SMTL ID
- 7eg3.1
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.2
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.3
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.4
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.5
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.6
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.7
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.8
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.9
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.10
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.11
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.12
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.13
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.14
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.15
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg3.16
- Ligands
- (2~{S})-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-2,3-dihydroinden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|